CompletedPhase 3

Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

639 participantsStarted 2006-09

Plain-language summary

The objective is to demonstrate equivalence of three IC51 batches in terms of Geometric Mean Titers for anti-JEV neutralizing antibody.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Main Inclusion Criteria: * Male and female subjects aged at least 18 years with written informed consent and either no childbearing potential or negative pregnancy test Main Exclusion Criteria: * History of immunodeficiency or immunosuppressive therapy, known HIV, drug addiction including alcohol dependence

What they're measuring

GMT for Anti-JEV Neutralizing Antibody

Timeframe: day 56

Trial details

NCT IDNCT00594958

SponsorValneva Austria GmbH

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2007-04

Results submitted2013-12-05

View on ClinicalTrials.gov More Japanese Encephalitis trials